Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Climate data for hygrothermal simulations of Brussels.
Vandemeulebroucke I, Caluwaerts S, Van Den Bossche N. Vandemeulebroucke I, et al. Among authors: caluwaerts s. Data Brief. 2022 Jul 26;44:108491. doi: 10.1016/j.dib.2022.108491. eCollection 2022 Oct. Data Brief. 2022. PMID: 36034638 Free PMC article.
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.
Mathieu C, Wiedeman A, Cerosaletti K, Long SA, Serti E, Cooney L, Vermeiren J, Caluwaerts S, Van Huynegem K, Steidler L, Blomme S, Rottiers P, Nepom GT, Herold KC; AG019-T1D-101 Trial Investigators. Mathieu C, et al. Among authors: caluwaerts s. Diabetologia. 2024 Jan;67(1):27-41. doi: 10.1007/s00125-023-06014-2. Epub 2023 Oct 2. Diabetologia. 2024. PMID: 37782353 Free PMC article. Clinical Trial.
A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes.
Sassi G, Licata G, Ventriglia G, Wouters A, Lemaitre P, Seurinck R, Mori A, Grieco GE, Bissenova S, Ellis D, Caluwaerts S, Rottiers P, Vandamme N, Mathieu C, Dotta F, Gysemans C, Sebastiani G. Sassi G, et al. Among authors: caluwaerts s. Diabetes. 2023 Oct 1;72(10):1470-1482. doi: 10.2337/db22-0852. Diabetes. 2023. PMID: 37494666 Free PMC article.
Characteristics of confirmed mpox cases among clinical suspects: A prospective single-centre study in Belgium during the 2022 outbreak.
Hens M, Brosius I, Berens-Riha N, Coppens J, Van Gestel L, Rutgers J, Kenyon C, Soentjens P, van Henten S, Bracke S, Vanbaelen T, Vandenhoven L, Bottieau E, Vercauteren K, Van Esbroeck M, Liesenborghs L, Van Dijck C; ITM mpox study groupc; ITM mpox study group. Hens M, et al. New Microbes New Infect. 2023 Feb 9;52:101093. doi: 10.1016/j.nmni.2023.101093. eCollection 2023 Mar. New Microbes New Infect. 2023. PMID: 36874154 Free PMC article.
Mpox screening in high-risk populations finds no asymptomatic cases.
Van Dijck C, De Baetselier I, Kenyon C, Liesenborghs L; ITM Monkeypox Study Group; Vercauteren K, Van Esbroeck M. Van Dijck C, et al. Lancet Microbe. 2023 Mar;4(3):e132-e133. doi: 10.1016/S2666-5247(22)00357-3. Epub 2022 Dec 9. Lancet Microbe. 2023. PMID: 36509096 Free PMC article. No abstract available.
51 results